Skip to main content

Table 4 Effect of the subchronic 13-week oral administration of POM93 on hematological parameters in Wistar rats

From: Genotoxicity and acute and subchronic toxicity studies of a bioactive polyoxometalate in Wistar rats

Time (d)

Hematological parameters

POM93 (mg/kg)

Control water

62.2

195.7

587.0

90

WBC (× 109/L)

14.20 ± 5.07

9.40 ± 2.91

12.20 ± 3.52

13.44 ± 4.33

RBC (× 1012/L)

9.11 ± 0.77

8.28 ± 1.16

8.67 ± 0.73

8.79 ± 1.91

PLT (× 109/L)

657.40 ± 402.57

334.20 ± 296.94

356.40 ± 247.47

536.56 ± 338.81

HB (g/L)

149.60 ± 11.88

142.50 ± 19.42

147.50 ± 15.36

144.67 ± 20.43

105

WBC (× 109/L)

15.36 ± 3.45

15.52 ± 4.18

16.90 ± 12.35

24.20 ± 10.20

RBC (× 1012/L)

8.96 ± 1.00

8.77 ± 0.91

8.72 ± 0.90

8.44 ± 0.81

PLT (× 109/L)

500.56 ± 185.23

490.90 ± 260.25

519.90 ± 343.95

587.67 ± 366.49

HB (g/L)

149.56 ± 13.91

152.20 ± 12.93

143.90 ± 12.41

135.17 ± 16.38

  1. Hematology profiles were within the normal range and unaffected by the POM93 treatment. Data are expressed as mean ± S.D. (n = 20)